Identifying treatment-resistant schizophrenia

descriptionPublicationkeyboard_double_arrow_right Article 01 Mar 2013 English Publisher:Royal College of PsychiatristsJournal:British Journal of Psychiatry, volume 202, pages 238-238 (issn: 0007-1250, eissn: 1472-1465,

Copyright policy )

Authors: Kiriakos, Xenitidis; Colin, Campbell; Ann, Mortimer;

doi: 10.1192/bjp.202.3.238

pmid: 23457184

Identifying treatment-resistant schizophrenia

- Summary
- Subjects
- Metrics

Abstract

I was surprised to read the paper of Howes et al .[1][1] No control group was investigated. This paper implies that any patient for whom a third antipsychotic is considered ought to be considered for clozapine, and if they are not started on clozapine, this constitutes an unacceptable delay. Such a

Related Organizations

University of Hull
United Kingdom

Keywords

Male, Schizophrenia, Humans, Female, Clozapine, Antipsychotic Agents

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average